A rapid clinical decision support system for breast cancer detection, BI-RADS classification, and molecular subtyping using multimodal imaging.
The Power of AI in Biotechnology
bioDNAtech develops clinical-focused biotechnology for early diagnosis, preventive medicine, and regenerative applications through Braivo, HealthyAge, and Autologous Exosome solutions.
Accepts MR, US, or mammography images as input.
OUR PRODUCTS
A Biotechnology Portfolio from Diagnostics to Longevity
Biological age, genetic advantages, and personalized health and lifestyle recommendations based on DNA methylation profiling.
A traceable regenerative approach derived from the individual's own biological material, aligned with GMP laboratory standards.
Clinical Decision Support Platform for Breast Imaging
BRAIVO is a hybrid analysis platform that supports MG, US, and breast MR images, integrates with PACS infrastructure, and sends studies to the AI model over a secure HTTPS connection.
MG
Mammography support
US
Ultrasound support
MR
Breast MRI support
PACS
DICOM integration
Problem
In traditional clinical workflows, additional imaging, biopsy planning, and waiting for pathology results can prolong decision-making for suspicious findings. BRAIVO aims to deliver rapid, standardized preliminary assessment from imaging studies.
BRAIVO-Enabled Workflow
- ✓ The study is sent directly to BRAIVO.
- ✓ AI-assisted image analysis is performed.
- ✓ BI-RADS estimation is generated automatically.
- ✓ Molecular subtype prediction is presented in the interface.
Deployment & Usage
- ✓ Orthanc, Python, and Node.js components are installed via the installer.
- ✓ The radiologist sends the relevant study from PACS.
- ✓ The study is listed automatically and analysis is started.
- ✓ Results are displayed within seconds.
Advantages
- ✓ Does not disrupt the existing radiology workflow.
- ✓ Offers multimodal analysis and a centrally updatable AI infrastructure.
- ✓ Uses a hybrid local deployment + cloud inference architecture.
- ✓ Produces standardized clinical decision support output.
Clinical Workflow
A streamlined process from routine imaging to decision support.
Presentation
The patient arrives for routine screening or with a lump complaint.
Imaging
Mammography, ultrasound, or breast MRI is performed.
AI Analysis
The image is transferred to the Braivo model for multi-layer analysis.
Decision Support
Output is generated to accelerate the diagnostic process for the radiologist.
Our Team
Scientific depth and management experience.
CEO
Prof. Dr. Gülşah
ÇEÇENER
✦
Bursa Uludağ University Faculty of Medicine, Medical Biology
✦
PhD — breast diseases and molecular genetics
✦
Cancer biology, miRNA, and exosome-based research
✦
381 publications · 128 WoS · 123 Scopus
Board Member
Cem KABAK
✦
Bilkent University Business, CUNY Baruch College MBA
✦
27 years of business experience, 19 years in C-Suite roles
✦
Independent Board Member · Automotive, Aluminum, Textiles, FMCG
✦
Company valuation, M&A, governance, finance
CONTACT
Let's connect for clinical and biotechnology partnerships.
The Braivo and bioDNAtech product portfolio offers a scalable infrastructure for early diagnosis, preventive medicine, and personalized health applications.
info@biodnatech.com Ulutek Technology Development Zone Management Inc.Bursa Uludağ University Görükle Campus, University 1st Street No: 933 Office: B03